INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 133 filers reported holding INTRA CELLULAR THERAPIES INC in Q4 2017. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $610,000 | +138.3% | 53,534 | +353.7% | 0.01% | +200.0% |
Q3 2018 | $256,000 | -76.5% | 11,799 | -80.9% | 0.00% | -71.4% |
Q2 2018 | $1,090,000 | -77.0% | 61,700 | -79.4% | 0.01% | -76.7% |
Q3 2017 | $4,734,000 | +396.7% | 300,000 | +1160.8% | 0.03% | +200.0% |
Q3 2015 | $953,000 | – | 23,794 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sarissa Capital Management LP | 640,000 | $25,626,000 | 6.33% |
Redmile Group, LLC | 1,322,592 | $52,957,000 | 4.01% |
SENZAR ASSET MANAGEMENT, LLC | 556,224 | $22,271,209,000 | 3.24% |
RA Capital Management | 314,349 | $12,587,000 | 1.81% |
WALL STREET ASSOCIATES | 205,657 | $8,235,000 | 1.58% |
Parametrica Management Ltd | 5,400 | $216,000 | 1.36% |
Rhenman & Partners Asset Management AB | 165,000 | $6,607,000 | 1.05% |
EAM Investors, LLC | 95,168 | $3,811,000 | 0.60% |
Rock Springs Capital Management LP | 180,000 | $7,207,000 | 0.58% |
WASATCH ADVISORS LP | 1,085,973 | $43,482,000 | 0.58% |